Atopic dermatitis

A practice parameter update 2012

Lynda Schneider*, Stephen Tilles, Peter Lio, Mark Boguniewicz, Lisa Beck, Jennifer Lebovidge, Natalija Novak, David Bernstein, Joann Blessing-Moore, David Khan, David Lang, Richard Nicklas, John Oppenheimer, Jay Portnoy, Christopher Randolph, Diane Schuller, Sheldon Spector, Dana Wallace

*Corresponding author for this work

Research output: Contribution to journalArticle

209 Citations (Scopus)

Abstract

This parameter was developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma and Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "Atopic dermatitis: a practice parameter update 2012." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. Published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology are available online at http://www.jcaai.org.

Original languageEnglish (US)
JournalJournal of Allergy and Clinical Immunology
Volume131
Issue number2
DOIs
StatePublished - Jan 1 2013

Fingerprint

Atopic Dermatitis
Allergy and Immunology
Joints
Hypersensitivity
Advisory Committees
Asthma
Pharmaceutical Preparations

Keywords

  • Atopic dermatitis/atopic eczema
  • Staphylococcus
  • allergen immunotherapy
  • cyclosporine
  • diagnosis
  • genetics
  • immunomodulating agents
  • management
  • pathogenesis
  • phototherapy
  • quality of life
  • sleep
  • therapy
  • triggers

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Schneider, L., Tilles, S., Lio, P., Boguniewicz, M., Beck, L., Lebovidge, J., ... Wallace, D. (2013). Atopic dermatitis: A practice parameter update 2012. Journal of Allergy and Clinical Immunology, 131(2). https://doi.org/10.1016/j.jaci.2012.12.672
Schneider, Lynda ; Tilles, Stephen ; Lio, Peter ; Boguniewicz, Mark ; Beck, Lisa ; Lebovidge, Jennifer ; Novak, Natalija ; Bernstein, David ; Blessing-Moore, Joann ; Khan, David ; Lang, David ; Nicklas, Richard ; Oppenheimer, John ; Portnoy, Jay ; Randolph, Christopher ; Schuller, Diane ; Spector, Sheldon ; Wallace, Dana. / Atopic dermatitis : A practice parameter update 2012. In: Journal of Allergy and Clinical Immunology. 2013 ; Vol. 131, No. 2.
@article{0c8fe49420a148c09bdd7e2369cdae4e,
title = "Atopic dermatitis: A practice parameter update 2012",
abstract = "This parameter was developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma and Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing {"}Atopic dermatitis: a practice parameter update 2012.{"} This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. Published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology are available online at http://www.jcaai.org.",
keywords = "Atopic dermatitis/atopic eczema, Staphylococcus, allergen immunotherapy, cyclosporine, diagnosis, genetics, immunomodulating agents, management, pathogenesis, phototherapy, quality of life, sleep, therapy, triggers",
author = "Lynda Schneider and Stephen Tilles and Peter Lio and Mark Boguniewicz and Lisa Beck and Jennifer Lebovidge and Natalija Novak and David Bernstein and Joann Blessing-Moore and David Khan and David Lang and Richard Nicklas and John Oppenheimer and Jay Portnoy and Christopher Randolph and Diane Schuller and Sheldon Spector and Dana Wallace",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.jaci.2012.12.672",
language = "English (US)",
volume = "131",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2",

}

Schneider, L, Tilles, S, Lio, P, Boguniewicz, M, Beck, L, Lebovidge, J, Novak, N, Bernstein, D, Blessing-Moore, J, Khan, D, Lang, D, Nicklas, R, Oppenheimer, J, Portnoy, J, Randolph, C, Schuller, D, Spector, S & Wallace, D 2013, 'Atopic dermatitis: A practice parameter update 2012', Journal of Allergy and Clinical Immunology, vol. 131, no. 2. https://doi.org/10.1016/j.jaci.2012.12.672

Atopic dermatitis : A practice parameter update 2012. / Schneider, Lynda; Tilles, Stephen; Lio, Peter; Boguniewicz, Mark; Beck, Lisa; Lebovidge, Jennifer; Novak, Natalija; Bernstein, David; Blessing-Moore, Joann; Khan, David; Lang, David; Nicklas, Richard; Oppenheimer, John; Portnoy, Jay; Randolph, Christopher; Schuller, Diane; Spector, Sheldon; Wallace, Dana.

In: Journal of Allergy and Clinical Immunology, Vol. 131, No. 2, 01.01.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Atopic dermatitis

T2 - A practice parameter update 2012

AU - Schneider, Lynda

AU - Tilles, Stephen

AU - Lio, Peter

AU - Boguniewicz, Mark

AU - Beck, Lisa

AU - Lebovidge, Jennifer

AU - Novak, Natalija

AU - Bernstein, David

AU - Blessing-Moore, Joann

AU - Khan, David

AU - Lang, David

AU - Nicklas, Richard

AU - Oppenheimer, John

AU - Portnoy, Jay

AU - Randolph, Christopher

AU - Schuller, Diane

AU - Spector, Sheldon

AU - Wallace, Dana

PY - 2013/1/1

Y1 - 2013/1/1

N2 - This parameter was developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma and Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "Atopic dermatitis: a practice parameter update 2012." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. Published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology are available online at http://www.jcaai.org.

AB - This parameter was developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma and Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "Atopic dermatitis: a practice parameter update 2012." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. Published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology are available online at http://www.jcaai.org.

KW - Atopic dermatitis/atopic eczema

KW - Staphylococcus

KW - allergen immunotherapy

KW - cyclosporine

KW - diagnosis

KW - genetics

KW - immunomodulating agents

KW - management

KW - pathogenesis

KW - phototherapy

KW - quality of life

KW - sleep

KW - therapy

KW - triggers

UR - http://www.scopus.com/inward/record.url?scp=84873400547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873400547&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2012.12.672

DO - 10.1016/j.jaci.2012.12.672

M3 - Article

VL - 131

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2

ER -